Prokidney (PROK) Prepaid Assets (2021 - 2026)
Prokidney's (PROK) quarterly Prepaid Assets came in at $2.8 million in Q2 2026, up 22.91% year-over-year from $2.3 million in Q2 2025, and down 8.3% quarter-over-quarter from $3.1 million in Q1 2026.
Analysis
Prokidney (PROK) Prepaid Assets (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Prepaid Assets for 6 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 22.91% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $2.8 million, a 22.91% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, down 33.02% from the prior year.
- Prepaid Assets was $2.8 million for Q2 2026 at Prokidney, down from $3.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.2 million in Q3 2024 and troughed at $524750.0 in Q2 2022.
- A 5-year average of $3.3 million and a median of $3.3 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 2577.3% in 2022 and slumped 43.54% in 2025, its largest moves.
- Over 5 years, Prepaid Assets stood at $2.6 million in 2022, then climbed by 29.54% to $3.4 million in 2023, then increased by 23.33% to $4.2 million in 2024, then tumbled by 33.02% to $2.8 million in 2025, then increased by 0.68% to $2.8 million in 2026.
- The last three Prepaid Assets figures came in at $2.8 million (Q2 2026), $3.1 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 Mn |
| Mar 31, 2026 | 3.08 Mn |
| Dec 31, 2025 | 2.81 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 4.19 Mn |
| Sep 30, 2024 | 6.23 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 4.95 Mn |
| Dec 31, 2022 | 2.62 Mn |
| Sep 30, 2022 | 3.55 Mn |
| Jun 30, 2022 | 524,750.00 |
| Mar 31, 2022 | 543,088.00 |
| Dec 31, 2021 | 588,000.00 |
| Sep 30, 2021 | 897,311.00 |